Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Endocrinology
•
Pituitary Disorders
•
Adrenal Disorders
How do you approach monitoring for autoimmune disorders in patients with surgical remission of Cushing’s disease, given the higher incidence of autoimmune disease in this population?
PMID:
38373302
Related Questions
What is the likelihood of recovery of the hypothalamic-pituitary-adrenal (HPA) axis in patients who develop immunotherapy induced adrenal insufficiency?
In patients with hypertension and suspected primary aldosteronism who have undergone negative confirmatory testing, what follow-up and monitoring strategies would you recommend to ensure early detection of potential aldosteronism?
When performing adrenal vein sampling, is calculating selectivity index using androstenedione superior to using cortisol alone for determining successful catheterization?
Does growth hormone (GH) replacement therapy reduce the risk of fractures in patients with GH deficiency?
Should we be using a cut off of 20 rather than the traditional 10 Hounsfield units to distinguish between benign and malignant adrenocortical tumors on imaging?
Does Entresto interfere with the measurement of ARR (Aldosterone to Renin Ratio) when working up a patient for hyperaldosteronism?
Do you recommend combined baseline cortisol and DHEA-S testing to improve the efficiency and accuracy of adrenal insufficiency diagnosis?
Is it necessary to prescribe a steroid taper after two weeks of high-dose prednisone (60 mg daily)?
Should we be aiming for normalization of both late-night salivary cortisol and 24hr urinary free cortisol levels when monitoring response to Cushing's disease treatment?
When and how do you taper off cabergoline therapy for treatment of microprolactinoma?
